What is the focus of drug therapy for women with polycystic ovary syndrome?

The focus of drug therapy for women with polycystic ovary syndrome (PCOS) primarily centers on regulating menstrual cycles and managing insulin resistance. PCOS is a complex endocrine disorder that often presents with irregular menstrual cycles, hyperandrogenism (excess male hormones), and insulin resistance, which can lead to obesity and increased risk of type 2 diabetes.

By addressing these issues, treatment regimens may include hormonal contraceptives to regulate menstrual cycles and anti-androgens to manage symptoms of excess testosterone. Additionally, medications such as metformin can improve insulin sensitivity, helping to alleviate the metabolic aspects of the syndrome and promoting normal ovulation.

While increasing fertility rates and lowering cholesterol levels can be important considerations in the management of women with PCOS, the primary aim of pharmacological intervention often remains focused on restoring regular menstrual cycles and addressing insulin resistance to improve overall health outcomes and mitigate the risk of long-term complications associated with the syndrome.